Search Results for "Zegerid"
Original Source: Zegerid OTC [MSD Consumer Care, Inc.]
Zegerid OTC
Matching Channels
None
Matching News
Santarus: Undervalued And Under The Radar
ByMacsJV:How important is a strong management team to a growing biopharmaceutical company? Just ask any of the Santarus share holders. The Santarus story should be a prerequisite for any CEO starting...
Validity of certain patent claims covering Santarus' Zegerid capsule and powder upheld
US drugmaker Santarus (Nasdaq: SNTS) saw its shares leap 14.2% to $7.06 in regular trading on September 4, adding a further 2.8% after hours, after the company said that the US Court of Appeals for th...
Santarus Shares Soar on Court Ruling
SAN DIEGO (AP) — Santarus Inc. said Tuesday that a federal appeals court partly reversed a lower court's decision that some of the patents supporting Santarus' acid reflux drug Zegerid were not vali...
Santarus sues Dr Reddy's over heartburn drug
(Reuters) - U.S. drugmaker Santarus Inc said it filed a lawsuit against Dr. Reddy's Laboratories, accusing the Indian drugmaker of infringing its patents on heartburn drug Zegerid.
Santarus Announces Appellate Court Reversal in Part of ZEGERID Invalidity Decision
Santarus, Inc. (NASDAQ: SNTS) today announced that the U.S. Court of Appeals for the Federal Circuit reversed in part a lower court decision of invalidity involving certain assert...
By Zacks Investment Research: After a big earnings beat two weeks ago, biotech company Santarus Inc (SNTS) became a Zacks #1 Rank Strong Buy on May 7. Since then, shares have climbed over 5%.Santarus...
Santarus' CEO Presents at UBS Global Life Sciences Conference (Transcript )
Santarus (SNTS) Presentation at UBS Global Life Sciences Conference September 19, 2012 4:00 p.m. ET Executives Gerald Proehl - President and CEO Presentation Gerald Proehl - President and...
2 Biotech Companies With Strong Product Launches To Monitor
By The Swiss Trader:A biotechnology company is allowed three-five years for speculation to drive stock's performance, but once sales are produced and FDA approvals occur, fundamentals must be the driv...
Matching PubMed Articles
None
